田雨：助理研究員，主要從事研究。

郵箱：1000006331@ujs.edu.cn

教育經曆:

2016-09 至 2022-09, 世界杯正规买球app, 臨床檢驗診斷學, 博士
2011-09 至 2016-06, 青海大學, 醫學檢驗(五年制), 學士

科研與學術工作經曆：

2022-12 至 今, 世界杯正规买球app, 世界杯正规买球app, 助理研究員

發表論文：

1. Tian Yu,Cao Yuwen,Chen Rong et al. HMGB1 A box protects neurons by potently inhibiting both microglia and T cell-mediated inflammation in a mouse Parkinson's disease model.[J] .Clin Sci (Lond), 2020, DOI: 10.1042/CS20200553.

2. Tian Yu,Chen Rong,Su Zhaoliang,HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson's Disease.[J] .Cell Mol Neurobiol, 2021, DOI: 10.1007/s10571-021-01170-8.

3. Zhou Lining,Tian Yu^#,Guo Fang et al. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.[J] .Cancer Immunol Immunother, 2020, DOI: 10.1007/s00262-020-02511-0.

4. Che Yang, Tian Yu^#,Chen Rong et al. IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C.[J] .Biochim Biophys Acta Mol Basis Dis, 2021, DOI: 10.1016/j.bbadis.2021.166171.（2021.9.1發表）

5. Cao Yuwen, Tian Yu^#,Liu Yueqin et al. Reg3β: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders.[J] .Int Rev Immunol, 2021, DOI: 10.1080/08830185.2020.1869731.（2021.1.11發表）

6. Chen Rong., Cao Yuwen., Tian Yu., Gu Yufeng., Lu Hongxiang., Zhang Shiqing., Xu Huaxi., Su Zhaoliang.(2020). PGE2 ameliorated viral myocarditis development and promoted IL-10-producing regulatory B cell expansion via MAPKs/AKT-AP1 axis or AhR signaling. Cell Immunol, 347(undefined), 104025. doi:10.1016/j.cellimm.2019.104025（2019.12.6發表）

7. Lu Hongxiang., Chen Rong., Barnie Prince Amoah., Tian Yu., Zhang Shiqing., Xu Huaxi., Chakrabarti Subrata., Su Zhaoliang.(2020). Fibroblast transdifferentiation promotes conversion of M1 macrophages and replenishment of cardiac resident macrophages following cardiac injury in mice. Eur J Immunol, 50(6), 795-808. doi:10.1002/eji.201948414（2020.6發表）

8. Huang Lan., Wan Jie., Wu Yinqiu., Tian Yu., Yao Yizheng., Yao Shun., Ji Xiaoyun., Wang Shengjun., Su Zhaoliang., Xu Huaxi.(2021). Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. Life Sci, 270(undefined), 119142. doi:10.1016/j.lfs.2021.119142（2021.4.1發表）

9. Wan Jie., Wu Yinqiu., Huang Lan., Tian Yu., Ji Xiaoyun., Abdelaziz Mohamed Hamed., Cai Wei., Dineshkumar Kesavan., Lei Yuqing., Yao Shun., Sun Caixia., Su Zhaoliang., Wang Shengjun., Xu Huaxi.(2021). ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8 T cells. Cancer Lett, 502(undefined), 34-43. doi:10.1016/j.canlet.2021.01.002（2021.4.1發表）

10. Li Jiali., Xia Lin., Liu Fang., Tian Yu., Chen Rong., Su Zhaoliang.(2021). lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPβ-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs. Clin Transl Med, 11(5), e407. doi:10.1002/ctm2.407（2021.5.11發表）

11. Chen Wenli., Yao Shun., Wan Jie., Tian Yu., Huang Lan., Wang Shanshan., Akter Farhana., Wu Yinqiu., Yao Yizheng., Zhang Xiaochun.(2021). BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. J Control Release, 333(undefined), 129-138. doi:10.1016/j.jconrel.2021.03.029（2021.5.10發表）

12. Chen Rong., Liu Fang., Xia Lin., Che Nan., Tian Yu., Cao Yuwen., Zhang Shiqing., Xu Huaxi., Su Zhaoliang.(2021). B10 cells decrease fibrosis progression following cardiac injury partially by IL-10 production and regulating hyaluronan secretion. J Leukoc Biol, undefined(undefined), undefined. doi:10.1002/JLB.3A0121-003RR（2021.5.19發表）

專利:

1.蘇兆亮; 田雨; 夏琳; 劉芳; 薛松磊 ; 一種重組HMGB1 A Box蛋白及其獲取方法與應用, 2022-05-26, 中國, CN202210581955.5 (專利)